• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Hyaluronan and proteoglycan link protein 2 (HAPLN2)

ACP19091

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP19091 Target NameHAPLN2
Target SynonymsBrain link protein 1; Bral1; Hapln2; HPLN2_HUMAN; Hyaluronan and proteoglycan link protein 2FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range27-340
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9GZV7
Background Information
  • Uniprot Id

    Q9GZV7

  • Target Species

    Human

  • Target Name

    HAPLN2

  • Target Full Name

    Hyaluronan and proteoglycan link protein 2

  • Target Function

    Mediates a firm binding of versican V2 to hyaluronic acid. May play a pivotal role in the formation of the hyaluronan-associated matrix in the central nervous system (CNS) which facilitates neuronal conduction and general structural stabilization. Binds to hyaluronic acid.

  • Target Subcellular Location

    Secreted, extracellular space, extracellular matrix.

  • Target Protein Families

    HAPLN family

  • Target Tissue Specificity

    Expressed only in adult brain.

  • Target Research Area

    Neuroscience

  • Target Synonyms

    Brain link protein 1; Bral1; Hapln2; HPLN2_HUMAN; Hyaluronan and proteoglycan link protein 2

Inquire Recombinant Human Hyaluronan and proteoglycan link protein 2 (HAPLN2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification